To determine whether IL-6 confers radioresistance on breast cancer cells, different concentrations (2.5 ng/ml and 5.0 ng/ml) of recombinant IL-6 was added to culture medium of breast cancer cells. The gene discussed is IL6; the disease is breast carcinoma.